compname announces q3 adjusted earnings per share $1.72.
q3 adjusted earnings per share $1.72.
q3 sales $4.7 billion versus refinitiv ibes estimate of $4.59 billion.
sees fy 2020 adjusted earnings per share $7.50 to $7.65.
now targeting full-year 2020 organic net sales growth of 5 percent and adjusted earnings per share of $7.50 to $7.65.
q3 personal care segment sales of $2.3 billion increased 1 percent.
delivered solid organic sales growth in q3, with good underlying performance and increased demand because of covid-19.
q3 consumer tissue segment sales of $1.6 billion increased 9 percent.
qtrly consumer tissue segment sales of $1.6 billion increased 9 percent.
sees fy adjusted operating profit growth of 8 to 10 percent.
outlook continues to assume no significant impact from potential supply chain disruptions as a result of covid-19.
sees fy net sales increase of 2 to 3 percent.
